Sanford Guide Antimicrobial
74
Quality Score
Strong
Sanford Guide Antimicrobial
Medium confidence
✍️ bumetric analysis
“
Sanford Guide Antimicrobial is an iOS app from Antimicrobial Therapy, Inc. in the Education category, currently rated 4.8★ across 1,850 ratings. Initial signal reads as largely positive sentiment, users highlighting consistency and feature depth.
Quality Score is 74: Strong (healthy traction). For a Education app, that means healthy traction. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$8.8K
per month
→
12-mo forecast
$9.1K – $19.1K
per month
→
24-mo forecast
$11.3K – $33.9K
per month
MID tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
🤖Also on Android
$771/mo · 2K ratings · 4.8★
View →
ONE-TIME · BUILD
💰 Estimated build cost
$60K
↳ What it cost to build · not monthly revenue
Likely range $45K – $80K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Pays back in ~2 months at current MRR
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Education complexity ×1.20 | +$10K |
Total estimate
$60K
ONE-TIME · EXIT VALUE
💵 Estimated acquisition value
$500K
↳ What it would sell for · not monthly revenue
Marketplace range $375K – $600K · 18× MRR multiple
💸
~8.3× return on build cost
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺 Ad-supported base | 15× MRR |
| ⭐ ★ rating ≥ 4.7 (premium) | +15% |
| 🏷 Education category multiple | +6% |
Final multiple
18× MRR
👥 Estimated audience size
155K
Lifetime downloads (US-equivalent)
Monthly active
27K
Daily active
8.2K
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
How we sized it
| 📲 Education engagement | ~85 installs / rating |
| 🔁 Education D30 retention | 18% |
| 📍 DAU / MAU stickiness | 0.30 |
DAU / MAU
30% sticky
🔬
How we forecast this revenue
MEDIUM CONFIDENCEBaseline
$8.8K/mo · ML-estimated from 234 triggers
Growth rate
+4.0% MoM · MID tier baseline (compound monthly)
6 months
$8.4K – $13.9K
12 months
$9.1K – $19.1K
24 months
$11.3K – $33.9K
Compound growth at +4.0% MoM (tier baseline for MID). Range widens with horizon — typical noise band ±25% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Below median · 54/100MID TIERunderperforming peersRevenue Strength
3.9
Product Quality
8.6
Market Position
0.0
Growth Velocity
5.0
Defensibility
7.5
Operational Safety
10.0
Founder Strength
7.0
Monetization Maturity
1.0
- 💰 Revenue: Modest — $6K - $13K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.78★ across 1,850 reviews — strong (top 10%).
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $158K-$281K. Portfolio play ($28K/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 11 of 11 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Paid app ($0.00)METRIC | +$2,800 | |
| Excellent rating (4.8★)METRIC | +$2,200 | |
| worth every pennyREVIEW | +$2,000 | |
| bugsREVIEW | −$1,800 | |
| 5 starREVIEW | +$1,800 | |
| excellent appREVIEW | +$1,500 | |
| Low install base (1,850 ratings)METRIC | +$1,500 | |
| Mature app (11y old)METRIC | +$1,500 | |
| highly recommendREVIEW | +$1,400 | |
| slowREVIEW | −$1,200 | |
| Single-language (English only)METRIC | −$400 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v7.2.4
Updated the Apple Sign In process to make it faster and smoother.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Sanford Guide Antimicrobial
- Developer
- Antimicrobial Therapy, Inc.
- Bundle ID
- com.sanfordguide.amt
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Today
- Description
- Find apps and games for iPhone, iPad, Mac, and more on the App Store.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $27.0K/mo
- Top-grossing rank
- 🇮🇳#6 /99 🇺🇸#7 /100 🇨🇦#12 /100 🇧🇷#12 /100 🇯🇵#14 /97 🇫🇷#32 /100 🇦🇺#34 /100
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth1,850 ratings+939% lifetimeShow 3-year history estimate ▾
Tracked (56 weeks) Pre-tracking estimate (33 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Top Countries — Grossing Rank9 countries
🇮🇳IN#6 /99
🇺🇸US#7 /100
🇨🇦CA#12 /100
🇧🇷BR#12 /100
🇯🇵JP#14 /97
🇫🇷FR#32 /100
🇦🇺AU#34 /100
🇩🇪DE#40 /99
🇬🇧GB#72 /100
📊Category Rank Trajectory#6 now · best #5 · worst #17
Lower line = better rank · Estimate from ratings growth model · Lower position on chart = worse rank · Higher = top of chart
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
Clinically Actionable, Concise Answers
Get exactly what you need to make the best decision in a fast-paced setting.
Institutionally Diverse Editorial Team by Design
Not every organization has the same patient population, budget, or processes. We bring perspectives from many medical institutions.
Constant Updates
New recommendations are added quickly by our nine-member editorial team.
‘Why Didn’t I Think of That’ Tools
An interactive antibacterial spectra chart, drug-drug interactions, and trustworthy calculators to define accurate dosing.
Praise from Providers… View full description on the official store →
Get exactly what you need to make the best decision in a fast-paced setting.
Institutionally Diverse Editorial Team by Design
Not every organization has the same patient population, budget, or processes. We bring perspectives from many medical institutions.
Constant Updates
New recommendations are added quickly by our nine-member editorial team.
‘Why Didn’t I Think of That’ Tools
An interactive antibacterial spectra chart, drug-drug interactions, and trustworthy calculators to define accurate dosing.
Praise from Providers… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 43 MB🔞 17+📱 iOS 15.0+🔖 v7.2.4🔄 updated 0d ago🌐 EN📂 Education💰 Paid
📅
What Worked™ · Development Pipeline
12 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-05
⭐
Rating ↑ 4.26 → 4.78 (improved 0.52★)
2026-05
📈
Crossed 500 ratings — social-proof flywheel kicking in
2026-03
⭐
Rating ↓ 4.84 → 4.26 (dropped 0.58★)
2026-03
⭐
Rating ↑ 4.26 → 4.84 (improved 0.58★)
2026-03
📈
Crossed 500 ratings — social-proof flywheel kicking in
2018-06
📈
Crossed 100 ratings — social-proof flywheel kicking in
2016-05
📈
Crossed 50 ratings — social-proof flywheel kicking in
2015-01
📈
Crossed 10 ratings — social-proof flywheel kicking in
2015-01
⭐
Rating ↑ 2.00 → 2.33 (improved 0.33★)
2015-01
⭐
Rating ↑ 1.57 → 2.00 (improved 0.43★)
2015-01
⭐
Rating ↑ 1.00 → 1.57 (improved 0.57★)
2014-09
🚀
First tracked snapshot — initial data captured
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
Full revenue analysis
Read the article-style breakdown for Sanford Guide Antimicrobial: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.
More by Antimicrobial Therapy, Inc.
View all →📦 Portfolio summaryINDIE studio
6apps·$28K/mocombined
⚠ Concentrated — top app contributes 94% of combined revenue (single-app dependency)
About this analysis
Why medium confidence: 1,850 ratings · no founder-verified revenue (model estimate only).
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does Sanford Guide Antimicrobial make per month?▴
Based on our ML-calibrated revenue forecast, Sanford Guide Antimicrobial earns approximately $26K/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
What apps are like Sanford Guide Antimicrobial?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes Sanford Guide Antimicrobial?▴
Sanford Guide Antimicrobial is published by Antimicrobial Therapy, Inc. on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is Sanford Guide Antimicrobial's BU Score?▴
Sanford Guide Antimicrobial has a BU Score of 74/100 (Strong). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.